Table 4.
Descriptive characteristics of the cohort.
| Characteristic | Description | Number with Data Available |
|---|---|---|
| Age * | 50.2 (+/− 17.1) years | 698 |
| Gender | ||
| Male | 86.6% (604) | 698 |
| Ethnicity | ||
| Hispanic/Latino | 23.6% (158) | 669 |
| Comorbidity | ||
| DM2 | 17.4% (121) | 697 |
| CAD | 7.9% (55) | 695 |
| HTN | 33.8% (236) | 698 |
| Hemodialysis | 0.4% (3) | 697 |
| Prior solid organ transplant | 0.4% (3) | 697 |
| COPD/asthma | 9.2% (64) | 695 |
| BMI * | 29.76 (+/− 6.1) | 639 |
| Any immunosuppression | 4.2% (29) | 697 |
| Symptoms | ||
| Respiratory | 75.3% (516) | 685 |
| Gastrointestinal | 46.3% (316) | 682 |
| Fever | 33.9% (231) | 682 |
| Headache | 20.9% (146) | 698 |
| Loss of taste and/or smell | 23.1% (161) | 698 |
| Laboratory Values | ||
| Peak CRP ** | 7.09 (2.58–14.62) mg/dL | 153 |
| Peak CPK ** | 167.0 (67.5–325.5) units/L | 79 |
| Peak D-dimer** | 0.94 (0.51–1.63) mg/L | 155 |
| Peak ferritin ** | 717 (332–1475) μg/L | 135 |
| Absolute lymphocytes (nadir) ** | 0.90 (0.60–1.43) 103/μL | 224 |
BMI: body mass index; DM2: type 2 diabetes mellitus; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; HTN: hypertension; CRP: C-reactive protein; CPK: creatinine phosphokinase. * Mean and standard deviation; ** median and range.